Hypersensitivity skin rash: An adverse drug reaction to clopidogrel loading dose [1]

International Journal of Cardiology

Volumn 95, Issue 2-3, 2004, Pages 333-

  Gowda, Ramesh M ^a   Misra, Deepika ^a   Khan, Ijaz A ^b  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiplatelet drugs; Clopidogrel; Hypersensitivity reaction; Skin rash

Indexed keywords

ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPHENHYDRAMINE; GLYCERYL TRINITRATE;

ADULT; ANALGESIA; ANAMNESIS; CARDIOVASCULAR RISK; CASE REPORT; CLINICAL FEATURE; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG MECHANISM; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERSENSITIVITY; LETTER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RASH; RISK REDUCTION; SIDE EFFECT; ST SEGMENT; UNSTABLE ANGINA PECTORIS;

EID: 2942518013     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.03.024     Document Type: Article

References (2)

1. Lerner R.G., Frishman W.H., Mohan K.T. Clopidogrel: a new antiplatelet drug. Heart Dis. 2:2000;168-173
2. CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE trial). Lancet. 348:1996;1329-1339